Chlorisondamine chloride

This classification denotes a nicotinic antagonist with the molecular formula C14H20Cl4N2.2Cl, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7B58W7756G, chemically known as 4,5,6,7-tetrachloro-2-(2-dimethylaminoethyl)-isoindoline dimethochloride but more generally known as chlorisondamine chloride, which bears US NIH Compound Identifier 6243. European Medicines Agency schedules Chlorisondamine chloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06182MIG. The term CHLORISONDAMINE CHLORIDE is an International Non-Proprietary Name. Most nations, for tariff and trade purposes, schedule chlorisondamine chloride under HS 29339990 and SITC 51577. As of Q4 2014, CHLORISONDAMINE CHLORIDE remains US FDA's Preferred Term for this commodity. Chlorisondamine chloride bears US NLM identifiers UMLS ID C0282099 and NCI Concept Code C76788. SMILES: C[N+]1(CC2C(C(C(C(C2CL)CL)CL)CL)C1)CC[N+](C)(C)C.[CL-].[CL-].